Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001242192 | SCV001415262 | likely pathogenic | not provided | 2019-11-12 | criteria provided, single submitter | clinical testing | This variant has been reported to affect PRPF8 protein function (PMID: 28515276). This variant has been observed in individual(s) with autosomal dominant retinitis pigmentosa (PMID: 11468273). ClinVar contains an entry for this variant (Variation ID: 3358). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with threonine at codon 2301 of the PRPF8 protein (p.Pro2301Thr). The proline residue is highly conserved and there is a small physicochemical difference between proline and threonine. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Pro2301 amino acid residue in PRPF8. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17061239, 23950152). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. |
OMIM | RCV000003522 | SCV000023680 | pathogenic | Retinitis pigmentosa 13 | 2001-07-15 | no assertion criteria provided | literature only |